SpectraCure's patent application relating to the technical solution in the new generation of treatment systems has been approved by the European Patent Office. The patent describes the technical solution that allows SpectraCure's treatment system to use the same optical fibers (light guide) to deliver the treatment light and to perform the measurements, to enable individual treatment. The solution of using the same optical fibers for measurement as for treatment, makes SpectraCure unique.

In addition to this new patent, SpectraCure has extensive patent protection for IDOSE®, the algorithms that regulate the treatment. Outside of Europe, the same patent application is in PCT phase, i.e. international examination. SpectraCure intends to seek patent protection in the most important markets outside of Europe.